supported by the National Basic Research Project (973 Program) of China (No.2014CB932200);the National Natural Science Foundation of China (Nos.81503016, 81771880, and 81401453);the Application Foundation and Cutting-edge Technologies Research Project of Tianjin (Young Program)(No.15JCQNJC13800).
Checkpoint blockade based immune therapy has shown to be effective but benefit only the minority of patients whose tumors have been pre-infiltrated by T cells. To overcome this obstacles, a PEG-modified Bi2Se3 nanocag...
National Basic Research Program of China(973 Program)(No.2015CB932100);National Natural Science Foundation of China(No.81473165);Liaoning Provincial Key Laboratory of Drug Preparation Design&Evaluation of Liaoning Provincial Education Department(LZ2014045);Liaoning Provincial Key Laboratory of Studying the Modern Drug preparations.
To achieve GSH-responsive 5-Fluorouridine(5-FU) delivery, a novel family of nanogel drug carriers has been successfully prepared. The new class of PAHy-based nanogels was prepared by the crossing-link reaction of poly...
National Natural Science Foundation of China (Grant No.81172992);the National Basic Research Program of China (973 Program,Grant No.2013CB932501);Innovation Team of Ministry of Education (Grant No.BMU20110263)
Considering the results of our previous research that conjugated linoleic acid mixture-paclitaxel (CLA-mixture-PTX) possesses anti-tumor activity against melanoma and brain glioma, the purpose of this study was to i...